Name | Number of supported studies | Average coverage | |
---|---|---|---|
pericyte | 13 studies | 28% ± 11% | |
endothelial cell | 9 studies | 24% ± 4% | |
smooth muscle cell | 6 studies | 24% ± 7% | |
endothelial cell of vascular tree | 4 studies | 20% ± 2% | |
fibroblast | 4 studies | 27% ± 5% | |
myofibroblast cell | 3 studies | 16% ± 1% | |
epithelial cell | 3 studies | 29% ± 4% |
Insufficient scRNA-seq data for expression of PELO at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 2270.75 | 1445 / 1445 | 100% | 15.02 | 183 / 183 |
stomach | 100% | 1537.03 | 359 / 359 | 100% | 16.52 | 286 / 286 |
lung | 100% | 2794.85 | 578 / 578 | 100% | 22.93 | 1153 / 1155 |
intestine | 100% | 2249.41 | 966 / 966 | 100% | 18.36 | 525 / 527 |
adrenal gland | 100% | 3967.91 | 258 / 258 | 100% | 40.29 | 229 / 230 |
uterus | 100% | 2175.78 | 170 / 170 | 100% | 22.24 | 457 / 459 |
breast | 100% | 1795.60 | 459 / 459 | 100% | 19.28 | 1113 / 1118 |
prostate | 100% | 1804.95 | 245 / 245 | 99% | 19.74 | 498 / 502 |
thymus | 100% | 1841.48 | 651 / 653 | 100% | 19.85 | 602 / 605 |
kidney | 100% | 2141.29 | 89 / 89 | 99% | 27.67 | 892 / 901 |
skin | 100% | 2074.17 | 1808 / 1809 | 99% | 21.96 | 467 / 472 |
bladder | 100% | 2099.33 | 21 / 21 | 99% | 19.23 | 497 / 504 |
ovary | 98% | 985.36 | 177 / 180 | 100% | 15.22 | 429 / 430 |
brain | 97% | 822.95 | 2565 / 2642 | 100% | 15.99 | 704 / 705 |
liver | 100% | 1442.71 | 226 / 226 | 96% | 14.32 | 388 / 406 |
pancreas | 93% | 604.16 | 304 / 328 | 100% | 23.20 | 178 / 178 |
adipose | 100% | 2160.82 | 1204 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 2922.72 | 1335 / 1335 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 100% | 14.49 | 29 / 29 |
spleen | 100% | 3277.76 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 23.28 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 8.28 | 1 / 1 |
muscle | 100% | 1562.21 | 802 / 803 | 0% | 0 | 0 / 0 |
heart | 99% | 1468.23 | 850 / 861 | 0% | 0 | 0 / 0 |
peripheral blood | 97% | 1421.97 | 901 / 929 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 94% | 10.74 | 75 / 80 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0060231 | Biological process | mesenchymal to epithelial transition |
GO_0070651 | Biological process | nonfunctional rRNA decay |
GO_0001833 | Biological process | inner cell mass cell proliferation |
GO_0051301 | Biological process | cell division |
GO_0072344 | Biological process | rescue of stalled ribosome |
GO_0032790 | Biological process | ribosome disassembly |
GO_0006417 | Biological process | regulation of translation |
GO_0007492 | Biological process | endoderm development |
GO_0051276 | Biological process | chromosome organization |
GO_0019827 | Biological process | stem cell population maintenance |
GO_0030513 | Biological process | positive regulation of BMP signaling pathway |
GO_0071025 | Biological process | RNA surveillance |
GO_0070966 | Biological process | nuclear-transcribed mRNA catabolic process, no-go decay |
GO_0070481 | Biological process | nuclear-transcribed mRNA catabolic process, non-stop decay |
GO_0022626 | Cellular component | cytosolic ribosome |
GO_1990533 | Cellular component | Dom34-Hbs1 complex |
GO_0005737 | Cellular component | cytoplasm |
GO_0043022 | Molecular function | ribosome binding |
GO_0170011 | Molecular function | stalled ribosome sensor activity |
GO_0046872 | Molecular function | metal ion binding |
GO_0005515 | Molecular function | protein binding |
Gene name | PELO |
Protein name | Protein pelota homolog (hPelota) (Protein Dom34 homolog) |
Synonyms | CGI-17 |
Description | FUNCTION: Component of the Pelota-HBS1L complex, a complex that recognizes stalled ribosomes and triggers the No-Go Decay (NGD) pathway . In the Pelota-HBS1L complex, PELO recognizes ribosomes stalled at the 3' end of an mRNA and engages stalled ribosomes by destabilizing mRNA in the mRNA channel . Following mRNA extraction from stalled ribosomes by the SKI complex, the Pelota-HBS1L complex promotes recruitment of ABCE1, which drives the disassembly of stalled ribosomes, followed by degradation of damaged mRNAs as part of the NGD pathway . As part of the PINK1-regulated signaling, upon mitochondrial damage is recruited to the ribosome/mRNA-ribonucleoprotein complex associated to mitochondrial outer membrane thereby enabling the recruitment of autophagy receptors and induction of mitophagy . . |
Accessions | ENST00000274311.3 Q9BRX2 |